Enzo Biochem, Inc. announced that Enzo’s board of directors (“Board”) has made a series of changes to the agenda for the upcoming Annual Meeting of Shareholders of the Company. As a result of these changes to the agenda, Enzo proposes to shareholders: To amend the bylaws to increase the size of the Board from five to six directors and provide the Board discretion to further increase the size of the Board to seven; To elect both nominees of Harbert Discovery Fund, LP (“Harbert”); Upon shareholder approval of the board size increase, to elect co-founder and significant shareholder Barry Weiner and to appoint a highly qualified and experienced, diverse independent director to be identified in the near future. In connection with these changes, Dr. Bruce Hanna, Ph.D. has decided to withdraw his candidacy.